Autolus Therapeutics (AUTL) Gross Profit: 2017-2025
Historic Gross Profit for Autolus Therapeutics (AUTL) over the last 8 years, with Sep 2025 value amounting to -$7.4 million.
- Autolus Therapeutics' Gross Profit rose 30.29% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.3 million, marking a year-over-year increase of 23.45%. This contributed to the annual value of -$1.3 million for FY2024, which is 174.62% down from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Gross Profit is -$7.4 million, which was down 111.50% from -$3.5 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Gross Profit peaked at $443.6 million during Q2 2023, and registered a low of -$30.1 million during Q4 2023.
- For the 3-year period, Autolus Therapeutics' Gross Profit averaged around $33.6 million, with its median value being -$7.4 million (2025).
- In the last 5 years, Autolus Therapeutics' Gross Profit tumbled by 939.97% in 2021 and then skyrocketed by 28,464.75% in 2022.
- Over the past 5 years, Autolus Therapeutics' Gross Profit (Quarterly) stood at $1.5 million in 2021, then surged by 163.34% to $3.8 million in 2022, then crashed by 887.66% to -$30.1 million in 2023, then spiked by 62.30% to -$11.4 million in 2024, then surged by 30.29% to -$7.4 million in 2025.
- Its Gross Profit stands at -$7.4 million for Q3 2025, versus -$3.5 million for Q2 2025 and -$9.0 million for Q1 2025.